Bit by bit, a growing body of evidence is leading psychiatry toward the goal of being able to treat patients on a highly individualized basis, based on their distinctive biology.
Read More
Researchers led by 2013 BBRF Young Investigator Conor Liston, M.D., Ph.D., have just reported a surprising finding about the drug ketamine, concerning the way it acts on the brain.
Approved many…
Read More
One of the most promising new therapy ideas for brain and behavior disorders may at first seem improbable: using opioid-based medicines to reduce the symptoms of depression. Isn’t our society in the…
Read More
Compounds that target a certain opioid receptor in the brain could be used to develop a new group of antidepressants, researchers reported in a study published in the journal Neuropsychopharmacology…
Read More
Animal research reported on March 21 in the journal Molecular Psychiatry has uncovered a drug development strategy that could lead to a new type of antidepressant medication. The study suggests that…
Read More
